[ad_1] MUMBAI: A US congressional panel has voiced concern on the ineffective action on quality lapses taken by its national drug regulator Food and Drug Administration (FDA) particularly in manufacturing facilities in India and China. Together, India and China supply approximately 32% of generic drugs, and nearly half of active pharmaceutical ingredients (APIs) to the … Read more
[ad_1] Second Richest Pharma Billionaire: Even though India is home to a number of pharmaceutical giants, few have been able to match or surpass Sun Pharmaceutical Industries Ltd.’s continuous development and expansion. Dilip Shanghvi, the founder and managing director of Sun Pharma, which is now India’s largest medical manufacturer, is primarily responsible for its unparalleled … Read more
[ad_1] NEW DELHI: Many newborns are dying because the antibiotics used to treat sepsis are losing their effectiveness, according to a global observational study which involved over 3,200 newborn babies suffering from the infection in 11 countries, including India.The study, conducted from 2018 to 2020 and co-authored by a team of over 80 researchers, found … Read more
[ad_1] MUMBAI: Price of patented drugs will be halved as soon as they lose patent protection or are on the verge of going off patent in India, providing much-needed relief to patients, reports Rupali Mukherjee.The price of the drug losing patent will be slashed by 50%, and after a year, the MRP will change in … Read more